Biogen (BIIB) on Watch Amid Renewed Chatter

August 8, 2016 11:30 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Biogen (NASDAQ: BIIB) was on watch amid renewed takeover chatter. Chatter suggests Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) may also be interested in the company. The source of the rumor was said to be DealReporter.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment